Apyx Medical Corp (APYX)

$0.98 +0.05 (4.84%)
Market Cap 38.55M
Revenue (ttm) 48.10M
Net Income (ttm) -23.46M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -48.77%
Debt to Equity Ratio 2.36
Volume 93,200
Avg Vol 48,520
Day's Range N/A - N/A
Shares Out 37.79M
Stochastic %K 42%
Beta 0.92
Analysts Sell
Price Target $3.25

Latest News on APYX

Renuvion wins 2025 NewBeauty Award for "Best Minimally Invasive Skin Tightener"

Mar 25, 2025, 9:00 AM EDT - 24 days ago

Renuvion wins 2025 NewBeauty Award for "Best Minimally Invasive Skin Tightener"

Apyx Medical Corporation (APYX) Q4 2024 Earnings Call Transcript

Mar 13, 2025, 11:48 AM EDT - 5 weeks ago

Apyx Medical Corporation (APYX) Q4 2024 Earnings Call Transcript

Apyx Medical Corporation Submits 510(k) Premarket Notification to the U.S. Food and Drug Administration for the AYON Body Contouring System™

Jan 6, 2025, 8:00 AM EST - 3 months ago

Apyx Medical Corporation Submits 510(k) Premarket Notification to the U.S. Food and Drug Administration for the AYON Body Contouring System™

Apyx Medical Corporation to Attend 15th Annual Craig-Hallum Alpha Select Conference

Nov 12, 2024, 4:05 PM EST - 5 months ago

Apyx Medical Corporation to Attend 15th Annual Craig-Hallum Alpha Select Conference

Apyx Medical Corporation (APYX) Q3 2024 Earnings Call Transcript

Nov 8, 2024, 1:39 PM EST - 5 months ago

Apyx Medical Corporation (APYX) Q3 2024 Earnings Call Transcript

Apyx Medical Corporation Announces $7,000,000 Million Registered Direct Offering

Nov 8, 2024, 7:05 AM EST - 5 months ago

Apyx Medical Corporation Announces $7,000,000 Million Registered Direct Offering

Apyx Medical Corporation Reports Third Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook and Introduces Full Year 2025 Financial Outlook

Nov 8, 2024, 7:00 AM EST - 5 months ago

Apyx Medical Corporation Reports Third Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook and Introduces Full Year 2025 Financial Outlook

Apyx Medical Corporation to Release Third Quarter Of Fiscal Year 2024 Financial Results on November 8, 2024

Oct 25, 2024, 8:00 AM EDT - 6 months ago

Apyx Medical Corporation to Release Third Quarter Of Fiscal Year 2024 Financial Results on November 8, 2024

Renuvion Named #1 Trusted Body Contouring Technology by Doctors*

Aug 13, 2024, 8:10 AM EDT - 8 months ago

Renuvion Named #1 Trusted Body Contouring Technology by Doctors*

Apyx Medical Corporation (APYX) Q2 2024 Earnings Call Transcript

Aug 11, 2024, 6:39 AM EDT - 8 months ago

Apyx Medical Corporation (APYX) Q2 2024 Earnings Call Transcript

Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Comparing the Use of Renuvion to a Competing Technology Following Liposuction or Body Contouring Procedures

Aug 8, 2024, 4:10 PM EDT - 9 months ago

Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Comparing the Use of Renuvion to a Competing Technology Following Liposuction or Body Contouring Procedures

Apyx Medical Corporation Reports Second Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook

Aug 8, 2024, 4:05 PM EDT - 9 months ago

Apyx Medical Corporation Reports Second Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook

Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024

Jul 25, 2024, 7:30 AM EDT - 9 months ago

Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024

Apyx Medical Corporation Launches the "Renewing Lives" Give-Back Campaign Providing Treatments with Renuvion to Benefit Physical Appearance and Mental Health

Jun 26, 2024, 7:30 AM EDT - 10 months ago

Apyx Medical Corporation Launches the "Renewing Lives" Give-Back Campaign Providing Treatments with Renuvion to Benefit Physical Appearance and Mental Health

Apyx Medical Corporation (APYX) Q1 2024 Earnings Call Transcript

May 11, 2024, 6:33 PM EDT - 1 year ago

Apyx Medical Corporation (APYX) Q1 2024 Earnings Call Transcript

Apyx Medical Corporation Reports First Quarter 2024 Financial Results; Reaffirms Full Year 2024 Financial Outlook

May 9, 2024, 7:05 AM EDT - 1 year ago

Apyx Medical Corporation Reports First Quarter 2024 Financial Results; Reaffirms Full Year 2024 Financial Outlook

Apyx Medical Corporation Announces Board Leadership Transition

May 9, 2024, 7:00 AM EDT - 1 year ago

Apyx Medical Corporation Announces Board Leadership Transition

Apyx Medical Corporation to Release First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024

Apr 25, 2024, 7:30 AM EDT - 1 year ago

Apyx Medical Corporation to Release First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024

Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users' Summit

Apr 11, 2024, 7:30 AM EDT - 1 year ago

Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users' Summit

Apyx Medical Corporation (APYX) Q4 2023 Earnings Call Transcript

Mar 21, 2024, 10:12 AM EDT - 1 year ago

Apyx Medical Corporation (APYX) Q4 2023 Earnings Call Transcript

Apyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial Outlook

Mar 21, 2024, 7:00 AM EDT - 1 year ago

Apyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial Outlook

Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024

Mar 4, 2024, 7:30 AM EST - 1 year ago

Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024

Apyx Medical Corporation Announces Renuvion to be Featured in Educational Sessions at the American Academy of Cosmetic Surgery (AACS) Scientific Meeting

Feb 21, 2024, 7:30 AM EST - 1 year ago

Apyx Medical Corporation Announces Renuvion to be Featured in Educational Sessions at the American Academy of Cosmetic Surgery (AACS) Scientific Meeting

Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Evaluating the Safety of Renuvion® Following Liposuction in Multiple Areas of the Body

Jan 22, 2024, 7:30 AM EST - 1 year ago

Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Evaluating the Safety of Renuvion® Following Liposuction in Multiple Areas of the Body

Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2023 Revenue Results

Jan 8, 2024, 7:00 AM EST - 1 year ago

Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2023 Revenue Results

Apyx Medical Corporation Appoints Matthew Hill as Chief Financial Officer

Nov 28, 2023, 8:30 AM EST - 1 year ago

Apyx Medical Corporation Appoints Matthew Hill as Chief Financial Officer

Apyx Medical Corporation (APYX) Q3 2023 Earnings Call Transcript

Nov 9, 2023, 11:30 AM EST - 1 year ago

Apyx Medical Corporation (APYX) Q3 2023 Earnings Call Transcript

Apyx Medical Corporation Announces New Debt Facility with Perceptive Advisors

Nov 9, 2023, 7:01 AM EST - 1 year ago

Apyx Medical Corporation Announces New Debt Facility with Perceptive Advisors

Apyx Medical Corporation Reports Third Quarter 2023 Financial Results and Updates Full Year 2023 Financial Outlook

Nov 9, 2023, 7:00 AM EST - 1 year ago

Apyx Medical Corporation Reports Third Quarter 2023 Financial Results and Updates Full Year 2023 Financial Outlook

Apyx Medical Corporation to Participate in Upcoming Investor Conferences in November

Nov 7, 2023, 7:30 AM EST - 1 year ago

Apyx Medical Corporation to Participate in Upcoming Investor Conferences in November

Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2023 Financial Results on November 9, 2023

Oct 2, 2023, 7:30 AM EDT - 1 year ago

Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2023 Financial Results on November 9, 2023

Apyx Medical Corporation (APYX) Q2 2023 Earnings Call Transcript

Aug 12, 2023, 12:09 PM EDT - 1 year ago

Apyx Medical Corporation (APYX) Q2 2023 Earnings Call Transcript

Apyx Medical Corporation Reports Second Quarter 2023 Financial Results and Reaffirms Full Year 2023 Financial Outlook

Aug 10, 2023, 4:05 PM EDT - 1 year ago

Apyx Medical Corporation Reports Second Quarter 2023 Financial Results and Reaffirms Full Year 2023 Financial Outlook

Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2023 Financial Results on August 10, 2023

Jun 29, 2023, 4:05 PM EDT - 1 year ago

Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2023 Financial Results on August 10, 2023

Apyx Medical Corporation Announces FDA 510(k) Clearance for the Renuvion® Micro Handpiece

Jun 14, 2023, 7:30 AM EDT - 2 years ago

Apyx Medical Corporation Announces FDA 510(k) Clearance for the Renuvion® Micro Handpiece

Apyx Medical Corporation (APYX) Q1 2023 Earnings Call Transcript

May 11, 2023, 10:21 AM EDT - 2 years ago

Apyx Medical Corporation (APYX) Q1 2023 Earnings Call Transcript

Apyx Medical Corporation Reports First Quarter 2023 Financial Results and Updates Full Year 2023 Financial Outlook

May 11, 2023, 7:00 AM EDT - 2 years ago

Apyx Medical Corporation Reports First Quarter 2023 Financial Results and Updates Full Year 2023 Financial Outlook

RENUVION® RECEIVES FDA CLEARANCE FOR SPECIFIC USE AFTER LIPOSUCTION

May 2, 2023, 7:30 AM EDT - 2 years ago

RENUVION® RECEIVES FDA CLEARANCE FOR SPECIFIC USE AFTER LIPOSUCTION

Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® for Coagulation of Subcutaneous Soft Tissues Following Liposuction for Aesthetic Body Contouring

Apr 28, 2023, 7:30 AM EDT - 2 years ago

Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® for Coagulation of Subcutaneous Soft Tissues Following Liposuction for Aesthetic Body Contouring

Apyx Medical Corporation to Release First Quarter of Fiscal Year 2023 Financial Results on May 11, 2023

Apr 5, 2023, 4:05 PM EDT - 2 years ago

Apyx Medical Corporation to Release First Quarter of Fiscal Year 2023 Financial Results on May 11, 2023

Renuvion Wins ADDY® Award for #ThisIsMe Campaign

Mar 27, 2023, 6:55 AM EDT - 2 years ago

Renuvion Wins ADDY® Award for #ThisIsMe Campaign

Apyx Medical Corporation (APYX) Q4 2022 Earnings Call Transcript

Mar 16, 2023, 11:30 AM EDT - 2 years ago

Apyx Medical Corporation (APYX) Q4 2022 Earnings Call Transcript

Apyx Medical Corporation Reports Fourth Quarter and Full Year 2022 Financial Results; Introduces Full Year 2023 Financial Outlook

Mar 16, 2023, 7:00 AM EDT - 2 years ago

Apyx Medical Corporation Reports Fourth Quarter and Full Year 2022 Financial Results; Introduces Full Year 2023 Financial Outlook

Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® to Coagulate and Contract Soft Tissues, Including Subcutaneous Tissue, Where Needed

Feb 27, 2023, 7:30 AM EST - 2 years ago

Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® to Coagulate and Contract Soft Tissues, Including Subcutaneous Tissue, Where Needed

Apyx Medical Corporation Announces New Five-Year Credit Agreement with MidCap Financial

Feb 21, 2023, 7:30 AM EST - 2 years ago

Apyx Medical Corporation Announces New Five-Year Credit Agreement with MidCap Financial

Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2022 Financial Results on March 16, 2023

Feb 16, 2023, 7:30 AM EST - 2 years ago

Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2022 Financial Results on March 16, 2023

RENUVION® COSMETIC NECK LAXITY PROCEDURE TO BE FEATURED ON 'THE BALANCING ACT' TALK SHOW ON LIFETIME® FEBRUARY 13

Feb 9, 2023, 7:30 AM EST - 2 years ago

RENUVION® COSMETIC NECK LAXITY PROCEDURE TO BE FEATURED ON 'THE BALANCING ACT' TALK SHOW ON LIFETIME® FEBRUARY 13

Apyx Medical Corporation Announces FDA 510(k) Submission for the Use of the Renuvion® APR Handpiece for the Coagulation of Subcutaneous Soft Tissues Where Needed, Following Liposuction

Feb 1, 2023, 7:30 AM EST - 2 years ago

Apyx Medical Corporation Announces FDA 510(k) Submission for the Use of the Renuvion® APR Handpiece for the Coagulation of Subcutaneous Soft Tissues Where Needed, Following Liposuction

APYX MEDICAL CORPORATION LAUNCHES NEW 'APYX ONE CONSOLE' FOR COSMETIC SURGICAL PROCEDURES IN THE UNITED STATES

Jan 25, 2023, 7:30 AM EST - 2 years ago

APYX MEDICAL CORPORATION LAUNCHES NEW 'APYX ONE CONSOLE' FOR COSMETIC SURGICAL PROCEDURES IN THE UNITED STATES

Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2022 Revenue Results

Jan 10, 2023, 7:00 AM EST - 2 years ago

Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2022 Revenue Results